Literature DB >> 31934168

TRB3 regulates pulmonary interstitial fibrosis through the MAPK signaling pathway.

Wencheng Yu1, Xiaoxia Song2, Yaqiu Liu3.   

Abstract

This study aims to investigate the effects of TRB3 on the EMT and MAPK signaling pathways in a bleomycin (BLM)-induced pulmonary fibrosis mouse model. TRB3 adenovirus vector with green fluorescent protein (GFP) and TRB3-siRNA adenovirus vector were constructed for overexpression and down-regulation of TRB3, respectively. The pulmonary fibrosis mouse model was induced by bleomycin, and then treated with adenovirus on the next day. The mice were randomly killed at the 7th (D7), 14th (D14) and 28th (D28) day, respectively. The lung tissues were collected for histopathologic observations, hydroxyproline determination, Immunohistochemistry, western blot and RT-qPCR to detect the expression of TRB3 and EMT-related proteins. Overexpression of TRB3 caused more severe pulmonary fibrosis (P<0.05), while downregulation of TRB3 significantly reduced pulmonary fibrosis (P<0.05). The expression of MAPK pathway-related and EMT-related genes and proteins was markedly upregulated by TRB3 overexpression (P<0.05), but prominently downregulated by TRB3-shRNA (P<0.05). In conclusion, exogenous regulation of TRB3 may have effects on bleomycin-induced pulmonary fibrosis in mice. IJCEP
Copyright © 2019.

Entities:  

Keywords:  EMT; MAPK signaling pathway; TRB3; idiopathic pulmonary fibrosis

Year:  2019        PMID: 31934168

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  6 in total

1.  TRAF6 Suppresses the Development of Pulmonary Fibrosis by Attenuating the Activation of Fibroblasts.

Authors:  Jiali Min; Qiao Li; Suosi Liu; Qianrong Wang; Min Yin; Yan Zhang; Jun Yan; Bing Cui; Shanshan Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

2.  Vincristine Promotes Transdifferentiation of Fibroblasts Into Myofibroblasts via P38 and ERK Signal Pathways.

Authors:  Hui Xu; Jingwen Yang; Mengyun Tu; Jie Weng; Mengying Xie; Zhiliang Zhou; Peisen Zhou; Liang Wang; Chan Chen; Zhiyi Wang
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

3.  TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension.

Authors:  Xiaopei Cao; Xiaoyu Fang; Mingzhou Guo; Xiaochen Li; Yuanzhou He; Min Xie; Yongjian Xu; Xiansheng Liu
Journal:  Respir Res       Date:  2021-12-14

4.  Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis.

Authors:  Yuxia Liu; Chang Xu; Wenxin Gao; Huaqiong Liu; Chenglong Li; Mingwei Chen
Journal:  Genet Res (Camb)       Date:  2022-07-16       Impact factor: 1.375

5.  Investigation of the Pharmacological Effect and Mechanism of Jinbei Oral Liquid in the Treatment of Idiopathic Pulmonary Fibrosis Using Network Pharmacology and Experimental Validation.

Authors:  Aijun Zhang; Yixuan Zou; Qingcui Xu; Shuo Tian; Jie Wang; Yilin Li; Renchao Dong; Liangzong Zhang; Juanjuan Jiang; Lili Wang; Kai Tao; Zhaoqing Meng; Yanqiu Liu
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

Review 6.  Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway.

Authors:  Naoki Inui; Satoshi Sakai; Masatoshi Kitagawa
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.